Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structured therapy interruption (STI) and deceptive imprinting.

Heinz Kohler1

  • 1ImmPheron Inc., Lexington, Kentucky 40509, USA. hkohl00@uky.edu

International Reviews of Immunology
|September 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The past, present, and future of anti-idiotype antibodies.

Frontiers in immunology·2025
Same author

Immune Jumping in Autoimmune Long-Covid.

Monoclonal antibodies in immunodiagnosis and immunotherapy·2024
Same author

Extensive Gaseous Emissions Reduction of Firewood-Fueled Low Power Fireplaces by a Gas Sensor Based Advanced Combustion Airflow Control System and Catalytic Post-Oxidation.

Sensors (Basel, Switzerland)·2023
Same author

Application of a Robust Thermoelectric Gas Sensor in Firewood Combustion Exhausts.

Sensors (Basel, Switzerland)·2023
Same author

What Can We Learn from Research with Monoclonal Antibody 1F7?

Monoclonal antibodies in immunodiagnosis and immunotherapy·2022
Same author

Expert Panel Discussion on Antigenic Sin.

Monoclonal antibodies in immunodiagnosis and immunotherapy·2021
Same journal

Leptin in metabolic-immune crosstalk: Mechanisms of T cell regulation and implications for autoimmune disease therapy.

International reviews of immunology·2026
Same journal

Metabolic alterations in the tumor microenvironment influence the anti-tumor immune function of CD8<sup>+</sup> T cells via epigenetic modifications.

International reviews of immunology·2026
Same journal

Macrophage markers and gene signature profiling reveals mesenchymal stem cells mediated immune modulation in Plasmodium berghei ANKA infection.

International reviews of immunology·2026
Same journal

Natural antigen landscape shaping intestinal Treg cells: Self, diet, and microbiota.

International reviews of immunology·2026
Same journal

Upregulation of ADAM10 reinforces CD8<sup>+</sup> T cells toward exhaustion in the TME.

International reviews of immunology·2026
Same journal

PTX3 promotes macrophage efferocytosis and inflammation resolution in granulomatous mastitis.

International reviews of immunology·2026
See all related articles

Chronic HIV-1 infection impairs immune responses. A new strategy combining structured treatment interruptions with immune response suppression may enhance therapy effectiveness against HIV-1.

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Chronic HIV-1 infection leads to immune system failure.
  • Viral 'Deceptive Imprinting' evades immune recognition, allowing persistent infection.
  • Highly Active Antiretroviral Therapy (HAART) interruption (STI) can cause 'wild-type' HIV-1 rebound, stimulating the immune system.

Purpose of the Study:

  • To propose a novel therapeutic strategy for chronic HIV-1 infection.
  • To enhance the immune-stimulating effects of Structured Treatment Interruptions (STI).
  • To investigate combining STI with suppression of dominant anti-wild-type HIV-1 immune responses.

Main Methods:

  • This study proposes a conceptual approach, not experimental methods.
  • The strategy involves a combination of therapeutic interventions.

Related Experiment Videos

  • Focuses on modulating the host immune response to viral rebound.

    • Main Results:

    • The proposed strategy aims to leverage viral rebound to re-educate the immune system.
    • Suppressing the dominant anti-wild-type response is hypothesized to improve overall immune control.
    • Enhanced immune stimulation is expected to lead to better disease management.

    Conclusions:

    • Combining STI with targeted immune suppression offers a potential new avenue for HIV-1 treatment.
    • This approach could overcome immune evasion mechanisms like 'Deceptive Imprinting'.
    • Further research and clinical trials are warranted to validate this therapeutic strategy.